Table 3.

Observed rates of hospitalization for CAP for ITP inpatients in the derivation and validation cohorts

Derivation cohort risk group (n = 1357)*Validation cohort risk group (n = 511)*
LowMediumHighLowMediumHigh
Risk score 0-3.5 4.5-8 9-10 0-3.5 4.5-8 9-10 
Patients without CAP 1072 (79.0) 150 (11.1) 1 (1.9) 373 (73.0) 74 (14.5) 2 (0.4) 
Patients with CAP 46 (3.4) 77 (5.7) 11 (5.9) 14 (2.7) 32 (6.3) 16 (3.1) 
Frequency of CAP 46/1118 (4.1) 77/227 (33.9) 11/12 (91.7) 14/387 (3.6) 32/106 (30.2) 16/18 (88.9) 
Derivation cohort risk group (n = 1357)*Validation cohort risk group (n = 511)*
LowMediumHighLowMediumHigh
Risk score 0-3.5 4.5-8 9-10 0-3.5 4.5-8 9-10 
Patients without CAP 1072 (79.0) 150 (11.1) 1 (1.9) 373 (73.0) 74 (14.5) 2 (0.4) 
Patients with CAP 46 (3.4) 77 (5.7) 11 (5.9) 14 (2.7) 32 (6.3) 16 (3.1) 
Frequency of CAP 46/1118 (4.1) 77/227 (33.9) 11/12 (91.7) 14/387 (3.6) 32/106 (30.2) 16/18 (88.9) 

All data are no. (%) unless otherwise specified.

*

A total of 148 patients in the derivation cohort and 78 patients in the validation cohort had no score because of lack of data for initial ALC.

Close Modal

or Create an Account

Close Modal
Close Modal